Polysubstance Detox: When More Than One Substance Is Involved

Why more than one substance changes everything

Federal treatment-admission data (the Treatment Episode Data Set) consistently show that a large share of people admitted to addiction treatment report more than one substance. Withdrawal from a single substance follows a known curve. Withdrawal from two or three does not simply add the curves together. Substances that act on the same brain system, such as alcohol and benzodiazepines, deepen each other’s withdrawal and raise the seizure risk above what either would carry alone. Substances that act in opposite directions, such as opioids and stimulants, mask each other, so the person looks calmer or more alert than their body actually is, and the clinician scoring symptoms gets a false reading. And the most common contaminant of all, fentanyl, is now found in counterfeit pills and in cocaine and methamphetamine supplies, which means many people are physically dependent on an opioid they never meant to take.

The most dangerous substance sets the timeline

The rule clinicians use is simple: whatever is in the mix, the medical risk is governed by the substance whose withdrawal can kill. If alcohol or a benzodiazepine is present, that timeline governs, with its seizure window in the first days and its delirium risk after. Opioid withdrawal, which is miserable but rarely fatal by itself, and the stimulant crash, which brings a depression deep enough to raise suicide risk, stack on top of it. The timeline above shows how the phases overlap. The practical consequence is that a person who thinks of themselves as “mostly a fentanyl user” but who drinks heavily every night needs an alcohol detox plan first, whatever they came in asking about.

The combinations that matter most in New Jersey

• Alcohol and benzodiazepines. The highest medical risk of any combination. Both act on the same receptors; stopping both at once without medication is how withdrawal seizures and delirium happen. This mix is always an inpatient detox.
• Opioids and benzodiazepines. Two respiratory depressants at once. The FDA carries a boxed warning on combining them for exactly this reason: the risk is profound sedation and stopped breathing. In detox, the benzodiazepine taper and the opioid plan run at the same time and the stay is longer than for either alone.
• Opioids and stimulants. The stimulant hides opioid sedation and the opioid hides stimulant agitation, which is why overdoses in this group are so often unexpected. In detox the two withdrawals arrive on different clocks: the stimulant crash first, the opioid peak a day or two later.
• Alcohol and cocaine. Used together, the liver produces cocaethylene, which stays active longer than cocaine and, in one emergency department study of 199 overdose patients, was associated with a higher rate of cardiac arrest than cocaine alone (6.1 percent versus 0.7 percent). It matters for the intake physical, not only the withdrawal plan.
• Fentanyl and xylazine. The animal tranquilizer that the New Jersey Department of Health reported in nearly half of suspected heroin or fentanyl seizures tested in early 2023 produces deep sedation that naloxone does not reverse, though naloxone should always be given for the fentanyl, and it causes wounds that need care during the stay. Xylazine withdrawal itself is poorly understood and is managed by symptoms.
• Anything plus gabapentin. Often overlooked. Gabapentin has a withdrawal syndrome of its own, including seizures at high doses, and people rarely list it because it was prescribed.

Tell them everything

The single most dangerous thing a person can do at a polysubstance intake is leave something off the list. People do it to seem less bad, to protect a prescription they want to keep, or because they do not think of alcohol, a sleep aid, or a “pressed” pill as counting. The plan that results is built for a different patient. Say what, how much, how often, when last, and whether any of it was bought rather than prescribed. If you are not sure what was in something, say that too; a urine screen catches some of it and honest uncertainty catches the rest. Your treatment records at a federally assisted program are protected by a federal confidentiality rule (42 CFR Part 2) that is stricter than ordinary medical privacy law: they cannot be used against you in a criminal case without a specific court order, and sharing them with police, employers, or immigration authorities requires your consent or one of the narrow exceptions that exist everywhere in medicine, such as a medical emergency, a court order, a report of suspected child abuse, or a crime committed on program premises. A 2024 update to the rule lets you sign a single consent that covers future treatment, payment, and health care operations, so read what you sign. Being honest about what you used is not an exception, and programs are not looking for a reason to turn you away.

What a polysubstance detox does differently

Two plans run at once. Alcohol or benzodiazepine withdrawal is managed with a scheduled benzodiazepine and symptom scoring, and for benzodiazepines a taper that usually continues after discharge. Opioid withdrawal is managed alongside it with buprenorphine, started once withdrawal has begun, or with comfort medications if buprenorphine is not the plan. Stimulant withdrawal is watched rather than medicated, with attention to sleep, food, and mood. Nursing checks are more frequent than for a single substance, the intake physical is more thorough because of the cardiac and liver questions the combinations raise, and in practice the stay usually runs longer, often five to ten days rather than three to five, and longer when a benzodiazepine taper is involved. A program that quotes you three days for an alcohol-and-Xanax detox is not the program.

Why outpatient does not work for this

Ambulatory detox, in which a clinician sees you daily while you sleep at home, is a legitimate option for low-risk single-substance withdrawal. It is almost never appropriate when two sedatives are involved, because the seizure risk cannot be watched from a clinic, or when opioids and benzodiazepines are combined, because the breathing risk peaks at night. The exception is a person whose only second substance is a stimulant or cannabis, where the medical risk is carried by one drug and a clinician may judge outpatient care reasonable. Let the assessment decide, and be honest in it.

After detox

Polysubstance use is strongly associated with co-occurring mental health conditions; SAMHSA’s National Survey on Drug Use and Health consistently finds that a large share of adults with a substance use disorder also have a mental illness in the same year, often because different substances were treating different symptoms. The step-down should be a program that treats both, and the medication decisions made in detox, in particular continuing buprenorphine or methadone, should be locked in before discharge. Overdose risk in the weeks after any detox is high, because tolerance drops while craving does not. Carry naloxone, do not use alone, and schedule the next level of care before you leave; our guide to what comes after detox explains how to choose it, and our facility checklist includes the questions that expose a program not equipped for combinations.